Value of a single C-reactive protein measurement at 18 h of age

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 99, Issue 1, 2014, Pages

  Lacaze Masmonteil, Thierry ^a,b   Rosychuk, Rhonda J ^b   Robinson, JoanL ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; EARLY ONSET SEPSIS; ESCHERICHIA COLI; FEMALE; GESTATIONAL AGE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

ANTIBIOTICS; C-REACTIVE PROTEIN; EARLY-ONSET NEONATAL SEPSIS; NEWBORN; PRETERM INFANT;

ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CANADA; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84890433766     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2013-303984     Document Type: Article

References (23)

1. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E coli disease continues. Pediatrics 2011;127:817-26.
2. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 2009;28:S3-9.
3. Kaiser JR, Cassat JE, Lewno MJ. Should antibiotics be discontinued at 48 h for negative late onset sepsis evaluation in the NICU? J Perinatol 2002;22:445-7.
4. Kumar Y, Qunibi M, Neal TJ, et al. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001;85:F182-6.
5. Escobar GJ. The neonatal sepsis work-up: personal reflections on the development of an evidence-based approach toward newborn infections in a managed care organization. Pediatrics 1999;103:360-73.
6. Escobar GJ, Li DK, Armstrong MA, et al. Neonatal Sepsis workups in infants >2000 grams at birth: a population- based study. Pediatrics 2000;106:256-63.
7. Polin RA. The 'Ins and Outs' of neonatal sepsis. J Pediatr 2003;143:3-4.
8. Sobko T, Schiott J, Ehlin A, et al. Neonatal sepsis, antibiotic therapy and later risk of asthma and allergy. Paediatr Perinat Epidemiol 2010;24:88-92.
9. Van Den Abbeele P, Verstraete P, El Aidy S, et al. Prebiotics, faecel transplants, and microbial network units to stimulate biodiversity of the human gut microbiome. Microb Biotechnol 2013;6:335-40.
10. Arnon S, Litmanovitz I. Diagnosic tests in neonatal sepsis. Curr Opin Infect Dis 2008;21:223-7.
11. Mishra UK, Jacobs SE, Doyle LW, et al. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006;91:F208-12.
12. Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol 2010;37:421-38.
13. Bomela HN, Ballot DE, Cory BJ, et al. Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis. Ped Infect Dis J 2000:19:531-5.
14. Benitz WE, Han MY, Madan A, et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998;102:e41.
15. Philip AG, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 2000;106:e4.
16. Pourcyrous M, Bada HS, Korones SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993;92:431-5.
17. McWilliam S, Riordan A. How to use: C-reactive protein. Arch Dis Child Educ Pract Ed 2010;95:55-8.
18. Hofer N, Zacharias E, Muller W, et al. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012;102:25-36.
19. Kaapa P, Koistinen E. Maternal and neonatal C-reactive protein after interventions during delivery. Acta Obstet Gynecol Scand 1993;72:543-6.
20. United Kingdom NICE guidelines 149. Antibiotics for the prevention and treatment of early onset neonatal infection. http://www.nice.org.uk/nicemedia/ live/13867/60633/60633.pdf
21. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London, UK: Arnold Publishing Co, 2000.
22. Hofer N, Muller W, Resh B. Non-infectious conditions and gestational age influence C-Reactive Protein values in newborns during the first 3 days of life. Clin Chem Lab Med 2011;49:297- 302.
23. Srinivasan L, Harris MC. New technologies for the rapid diagnosis of neonatal sepsis. Current Opinion Pediatr 2012;24:165-71.